Intuitive Surgical, Inc.

    ISRG ·NASDAQ ·Orthopedic, Prosthetic & Surgical Appliances & Supplies ·Inc. in DE
    Loading chart...

    Loading financial statements...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    Loading holders...

    Held by

    holders ( registered funds via N-PORT, institutional investors via 13F). Showing top by dollar value.

    Holder Type ETF MF Position ($) % of holder Δ % of holder Holder AUM

    Recent insider activity

    Last 90 days. Open-market trades (purchases & sales) by directors, officers, and 10%+ owners. 2 transactions across 1 insider. Net: -619 shares, -$291,886.

    Date Insider Role Action Shares Price Value
    2026-04-29 Ladd Amy L Director Sell -119 $463.50 -$55,156
    2026-04-28 Ladd Amy L Director Sell -500 $473.46 -$236,730

    Source: SEC Form 4 filings.

    Next expected filings

    • ~2026-07-23 10-Q expected by 2026-08-11 (in 83 days)
    • ~2026-10-22 10-Q expected by 2026-11-10 (in 174 days)
    • ~2027-02-05 10-K expected by 2027-03-05 (in 280 days)
    • ~2027-04-22 10-Q expected by 2027-05-11 (in 356 days)

    Predicted from historical filing cadence; not an SEC commitment.

    Recent SEC filings

    • 2026-04-22 10-Q Quarterly Report
    • 2026-04-21 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-03-02 8-K Other Events; Financial Statements and Exhibits
    • 2026-02-03 10-K Annual Report
    • 2026-01-22 8-K Earnings Release; Financial Statements and Exhibits
    • 2026-01-14 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-12-18 8-K Officer/Director Change
    • 2025-10-22 10-Q Quarterly Report
    • 2025-10-21 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-07-23 10-Q Quarterly Report
    • 2025-07-22 8-K Earnings Release; Financial Statements and Exhibits
    • 2025-05-15 8-K Officer/Director Change; Regulation FD Disclosure; Financial Statements and Exhibits
    • 2025-05-05 8-K Officer/Director Change; Shareholder Vote Results; Regulation FD Disclosure
    • 2025-04-23 10-Q Quarterly Report
    • 2025-04-22 8-K Earnings Release; Financial Statements and Exhibits